Introducing Amgen’s RISE Program

People of Amgen BC: Desiree Lim

#WhyISci: Amgen Scholars on Helping Others Through STEM

A conversation with your doctor can help address postmenopausal #osteoporosis head-on.

Health and Technology: Amgen Inc.: Pursuing Innovation and Imitation?

Amgen partners with China's BeiGene on cancer drug research

Amgen's Commitment to ESG

The Answers Within - Biology First

UTokyo Amgen Scholars Program in Japan (worth 250,000 JPY as Stipend)

Amgen sinks as Cantor flags issues with obesity drug

Patent Robustness After Amgen: Drafting Specifications to Satisfy the 112 Requirements of Tomorrow

Biotechnology and Healthcare: A New Dawn? With Bob Bradway, CEO of Amgen

FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics deal

#WhyISci: Amgen Scholars on STEM Discovery and Learning

A New Approach to Migraines from Amgen

Amgen Trade Show Booth

Amgen’s Bi-Annual Health Equity Summit (Spring 2022)

CE Pharm 2020 Keynote: Patrick Swann, Amgen Inc.

Amgen News Mockumentary

Ep. 27 - Amgen's David Reese